title: Association of the calcyon gene (DRD1IP) with attention deficit/hyperactivity disorder.
abstract: Attention deficit/hyperactivity disorder (ADHD) is a childhood-onset disorder characterized by marked inattention, hyperactivity and impulsivity. The dopaminergic system has been hypothesized to be involved in the development of ADHD. Positive associations have been found for the dopamine receptors D1 and D5 genes, suggesting that other genes involved in D1/D5 signalling may also contribute to ADHD. In this study, we tested the calcyon gene (DRD1IP), which encodes a brain-specific D1-interacting protein involved in D1/D5 receptors calcium signalling, for association with ADHD. The inheritance of nine polymorphisms in the calcyon gene was examined in a sample of 215 nuclear families, with 260 affected children, using the transmission/disequilibrium test. The most common haplotype, designated C1, demonstrated significant evidence for excess transmission. Quantitative trait analyses of this haplotype showed significant relationships with both the inattentive (parent's rating, P=0.006; teacher's rating, P=0.003) and hyperactive/impulsive (parent's rating, P=0.004) dimensions of the disorder. Two of the nine marker alleles included in haplotype C1, rs4838721A located approximately 10 kb 5' of the gene and rs2275723C located 10 bp upstream of the exon 5 acceptor splice site, also showed significant evidence for association when analysed individually. As these two variants are not predicted to alter calcyon function, we screened the gene exons by sequencing. No variation in the coding region was identified, suggesting that a causal variant allele resides elsewhere in a regulatory sequence of the gene. These findings support the proposed involvement of the calcyon gene in ADHD and implicate haplotype C1 as containing a risk allele.
authors.affiliation: Cell and Molecular Biology Division, Toronto Western Research Institute, University Health Network, Toronto, ON, Canada.
authors.forename: N
authors.initials: N
authors.lastname: Laurin
authors.forename: V L
authors.initials: VL
authors.lastname: Misener
authors.forename: J
authors.initials: J
authors.lastname: Crosbie
authors.forename: A
authors.initials: A
authors.lastname: Ickowicz
authors.forename: T
authors.initials: T
authors.lastname: Pathare
authors.forename: W
authors.initials: W
authors.lastname: Roberts
authors.forename: M
authors.initials: M
authors.lastname: Malone
authors.forename: R
authors.initials: R
authors.lastname: Tannock
authors.forename: R
authors.initials: R
authors.lastname: Schachar
authors.forename: J L
authors.initials: JL
authors.lastname: Kennedy
authors.forename: C L
authors.initials: CL
authors.lastname: Barr
mesh_terms: D000293:Adolescent; D001289:Attention Deficit Disorder with Hyperactivity / Q000145:classification / Q000235:genetics* / Q000378:metabolism; D020013:Calcium Signaling / Q000235:genetics*; D002648:Child; D005260:Female; D005787:Gene Frequency / Q000235:genetics; D006239:Haplotypes; D006801:Humans; D015810:Linkage Disequilibrium; D008297:Male; D008565:Membrane Proteins / Q000235:genetics*; D010375:Pedigree; D040641:Quantitative Trait Loci; D017447:Receptors, Dopamine D1 / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology
chemical_list: D008565:Membrane Proteins; D017447:Receptors, Dopamine D1; C405464:calcyon